Friday, February 26, 2021 12:28:06 PM
And as a disclaimer, I dumped immediately and then started looking for evidence on whether I wanted to buy back in. I am not going to do so.
Here's what apparently happened. On Nov 6, Zimmerman Biopharma (aka Sixty Six Oilfield Services)(trading as SSOF and domiciled in Florida) filed with the SEC to revoke their request for permission to do an offering at 18c per share. Zimmerman might have been an officer at that point, but his name was not on the Florida paperwork. David J. Wood WAS listed (along with Bland) on the Florida corporate papers.
So, when they withdrew their application from the SEC, that must have been when Zimmerman and Wood decided to exit SSOF. The deal probably got rescinded (exactly as I said).
Then, on Nov 18, 2020, Biologx gets created. By that time, Zim and Wood were gone from SSOF, so the statement today by Manhattan Cap is technically correct. I am guessing for legal reasons, they didn't want to get into the matters regarding how Zim and Wood had just days prior been at SSOF and had perhaps left.
The only remaining question in my mind was why Florida has Wood still on the business papers as CEO or whatever. Well, usually these changes don't have to be updated for a long time, and I'm guessing that's the same case in Florida.
So, SSOF is a shell that should IMHO be valued at about 0.0004 per share until such a time as Bland comes up with a new business.
I am obviously NOT an investment advisor.
Recent SSOF News
- Form C-AR - Annual Report • Edgar (US Regulatory) • 05/16/2024 06:35:25 PM
FEATURED Element79 Gold Corp Shares Further Advances With Chachas Community on Lucero Surface Rights, Provides Corporate Update • Oct 28, 2024 10:25 AM
VAYK Clarifies It Has No Business Connection to Persons Under SEC Charge • VAYK • Oct 28, 2024 11:59 AM
Vocodia Enters Medical Alert Industry with Innovative Emergency Response Pendant • VHAI • Oct 25, 2024 8:00 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024 • HYDI • Oct 24, 2024 11:18 AM
VAYK Asserts Goal of Q4 Operationally Profitable and Projects Major 2025 Launch • VAYK • Oct 24, 2024 10:40 AM
CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push • CBDL • Oct 24, 2024 7:07 AM